investigators observe differences in toxicity for sarcoma due to dosing
Published 4 years ago • 68 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
8:14
chemotherapy toxicity considerations in soft tissue sarcoma
-
1:59
neoadjuvant blockade demonstrates significant clinical activity in ups
-
1:41
differences in soft tissue sarcoma incidences and clinical characteristics between france and taiwan
-
28:05
advances in therapy for sarcomas & gist
-
8:17
chemotherapy sensitivity in soft tissue sarcoma
-
33:05
comparing fusion detection assays using sarcoma samples
-
8:17
targeted therapy advancements in sarcoma subtypes
-
8:38
frontline approach in advanced sarcomas
-
16:13
ezh2 inhibition in swi/snf altered sarcomas
-
44:52
adult sarcomas bcop 2021
-
48:47
dr. roman groisberg discusses sarcoma via the oncliveonair podcast
-
1:01:43
research review: promising research advancements in sarcoma
-
0:59
utilizing ngs to identify molecular targets in advanced sarcoma
-
3:59
where does immunotherapy fit in the treatment landscape of sarcoma?
-
1:58
the convergence of targeted therapies and immuno-oncology in sarcoma
-
1:55:26
sarcoma academy - molecular diagnostics in sarcoma
-
8:14
efficacy and toxicities with trabectedin in sarcomas
-
21:46
2021 west oncology app | update on sarcoma
-
8:02
sequencing decisions in soft tissue sarcoma